Chad Holtzman is senior counsel at Grant & Eisenhofer, focusing his practice on recovering damages for businesses and consumers harmed by violations of the federal and state antitrust laws, including price-fixing and monopolization.
Currently, Mr. Holtzman is a member of leadership teams representing clients in high-profile antitrust cases in the pharmaceutical, financial services, and commodities industries, including: In re Blue Cross Blue Shield Antitrust Litigation, In re London Silver Fixing, Ltd. Antitrust Litigation, In re Generic Pharmaceuticals Pricing Antitrust Litigation, In re Novartis and Par Antitrust Litigation (Exforge), In re: Humira (Adalimumab) Antitrust Litigation, and In re Lipitor Antitrust Litigation, among others.
Prior to joining Grant & Eisenhofer, Mr. Holtzman worked as an associate at the Philadelphia office of a national Am Law 100 law firm where he defended corporate defendants in antitrust and other complex commercial litigation.
Mr. Holtzman is a member of the Committee to Support the Antitrust laws (COSAL), established to preserve and enhance the private enforcement of strong antitrust laws. He is a member of the American Antitrust Institute and the American Bar Association’s Antitrust Division. Finally, Mr. Holtzman serves on the National Board for the Jewish National Fund Young Professionals Division as its Vice President. He is also a Board Member of the International Alliance for Child Literacy, a non-profit charity that empowers children by establishing libraries at orphanages.
Mr. Holtzman earned his J.D., cum laude, from Villanova University School of Law in 2009 where he was the Associate Editor for the Villanova Environmental Law Journal. Mr. Holtzman earned his B.S. in economics from Hamilton College in 2006.